Select Publications
Journal articles
2024, 'Rapid Attenuation of B-Cell and IFN-γ–Associated Chemokines in Clinical Responders to Jak Inhibition with Upadacitinib in Hidradenitis Suppurativa', Journal of Investigative Dermatology, 144, pp. 416 - 419.e5, http://dx.doi.org/10.1016/j.jid.2023.07.023
,2024, 'Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial', Journal of Investigative Dermatology, http://dx.doi.org/10.1016/j.jid.2023.10.005
,2024, 'Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis', Experimental Dermatology, 33, http://dx.doi.org/10.1111/exd.14978
,2023, 'Resident cutaneous memory T cells: a clinical review of their role in chronic inflammatory dermatoses and potential as therapeutic targets', British Journal of Dermatology, 189, pp. 656 - 663, http://dx.doi.org/10.1093/bjd/ljad303
,2023, 'Reply to Tilotta and Bongiorno: Considering the role of resident cutaneous memory T-cell suppression in providing durable atopic dermatitis remission', Journal of the European Academy of Dermatology and Venereology, 37, pp. e1173 - e1174, http://dx.doi.org/10.1111/jdv.19179
,2023, 'Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis', Melanoma Research, 33, pp. 316 - 325, http://dx.doi.org/10.1097/CMR.0000000000000900
,2023, 'Chemotherapy in Cutaneous Melanoma: Is There Still a Role?', Current Oncology Reports, 25, pp. 609 - 621, http://dx.doi.org/10.1007/s11912-023-01385-6
,2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605
,2023, 'Academic dermatology in Australia and New Zealand between 2017 and 2022: A cross-sectional bibliometric analysis', Australasian Journal of Dermatology, 64, pp. 213 - 220, http://dx.doi.org/10.1111/ajd.14025
,2023, 'Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies?', Australasian Journal of Dermatology, 64, pp. e204 - e206, http://dx.doi.org/10.1111/ajd.14009
,2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649
,2023, 'Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.19615
,2023, 'Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.16942
,2023, 'The serum proteome of pyoderma gangrenosum is more expansive than that of hidradenitis suppurativa', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.19611
,2022, 'Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000058
,2022, 'Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series', Australasian Journal of Dermatology, 63, pp. 522 - 524, http://dx.doi.org/10.1111/ajd.13925
,2022, 'BRAF inhibition and the spectrum of granulomatous reactions', Journal of the American Academy of Dermatology, 87, pp. 605 - 613, http://dx.doi.org/10.1016/j.jaad.2021.10.030
,2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010
,2022, 'A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions', Australasian Journal of Dermatology, 63, pp. e279 - e282, http://dx.doi.org/10.1111/ajd.13866
,2022, 'Acute generalised exanthematous pustulosis and cutaneous vasculitis: Not always just pustules?', Australasian Journal of Dermatology, 63, pp. 136 - 139, http://dx.doi.org/10.1111/ajd.13776
,2021, 'Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor', Skin Health and Disease, 1, http://dx.doi.org/10.1002/ski2.71
,2021, 'Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis', Journal of Dermatology, 48, pp. 1619 - 1621, http://dx.doi.org/10.1111/1346-8138.16073
,Conference Papers
2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403
,2022, 'Pathology/
Conference Abstracts
2022, 'BRAF inhibition and the spectrum of Granulomatous Reactions', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 106 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'If your ears are burning we must be talking about Red Ear Syndrome: A case report', in Australasian Journal of Dermatology, Wiley, Vol. 63, pp. e244 - e246, presented at Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.13862
,2022, 'Morbiliform eruption and Systemic Inflammatory Response Syndrome following COVID-19 mRNA vaccination', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,